Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease.
- Published In:
- Aging, 4(11), 755-67 (2012)
- Authors:
- Jaszberenyi, Miklos, Rick, Ferenc G(6), Szalontay, Luca(3), Block, Norman L, Zarandi, Marta, Cai, Ren-Zhi, Schally, Andrew V
- Database ID:
- RPEP-01969
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-01969APA
Jaszberenyi, Miklos; Rick, Ferenc G; Szalontay, Luca; Block, Norman L; Zarandi, Marta; Cai, Ren-Zhi; Schally, Andrew V. (2012). Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease.. Aging, 4(11), 755-67.
MLA
Jaszberenyi, Miklos, et al. "Beneficial effects of novel antagonists of GHRH in different models of Alzheimer's disease.." Aging, 2012.
RethinkPeptides
RethinkPeptides Research Database. "Beneficial effects of novel antagonists of GHRH in different..." RPEP-01969. Retrieved from https://rethinkpeptides.com/research/jaszberenyi-2012-beneficial-effects-of-novel
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.